IP Verse

Wittkopp patent opposition analysis

The comprehensive analysis of Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wittkopp

Stay updated with the latest patent oppositions filed by Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4406594
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALSJun 9, 2026SYNTHON
EP2965752
Pharmaceutical Formulation Comprising EzetimibeRATIOPHARMJun 3, 2026HAMM & WITTKOPP
EP3676404
Methods Of Selecting A Treatment For Cancer PatientsNOVARTISJun 3, 2026STADA ARZNEIMITTEL
EP4385509
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 2, 2026HAMM & WITTKOPP
EP4034122
Methods For Treating HyperphenylalaninemiaPTC THERAPEUTICS MPMay 12, 2026HAMM & WITTKOPP
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKMay 5, 2026SYNTHON
EP4426307
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026HAMM & WITTKOPP
EP3449911
Pharmaceutical FormulationsARRAY BIOPHARMAMar 18, 2026HAMM & WITTKOPP
EP3908276
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMar 11, 2026SYNTHON
EP3411021
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 16, 2026ALFRED E TIEFENBACHER

Top clients of Wittkopp

Top companies who are the clients of Wittkopp

CompanyTotal
STADA ARZNEIMITTEL74
HAMM & WITTKOPP67
ALFRED E TIEFENBACHER47
SYNTHON26
BETAPHARM ARZNEIMITTEL11
POLPHARMA10
WITTKOPP9
TEVA PHARMACEUTICALS4
ALVOGEN IPCO3
G L PHARMA3